These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36834486)
1. Expanding the Disease Network of Glioblastoma Multiforme via Topological Analysis. Badkas A; De Landtsheer S; Sauter T Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834486 [TBL] [Abstract][Full Text] [Related]
2. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. Liang Y; Bollen AW; Aldape KD; Gupta N BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952 [TBL] [Abstract][Full Text] [Related]
3. Gene co-expression network construction and analysis for identification of genetic biomarkers associated with glioblastoma multiforme using topological findings. Redekar SS; Varma SL; Bhattacharjee A J Egypt Natl Canc Inst; 2023 Jul; 35(1):22. PubMed ID: 37482563 [TBL] [Abstract][Full Text] [Related]
4. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma. Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484 [No Abstract] [Full Text] [Related]
5. SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme. Yan Y; Zhang L; Xu T; Zhou J; Qin R; Chen C; Zou Y; Fu D; Hu G; Chen J; Lu Y PLoS One; 2013; 8(11):e81905. PubMed ID: 24278465 [TBL] [Abstract][Full Text] [Related]
6. Role of glycosyltransferase PomGnT1 in glioblastoma progression. Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363 [TBL] [Abstract][Full Text] [Related]
7. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme. Akçay S; Güven E; Afzal M; Kazmi I Gene; 2022 May; 824():146395. PubMed ID: 35283227 [TBL] [Abstract][Full Text] [Related]
8. Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis. Wang Q; Zhang L; Cui Y; Zhang C; Chen H; Gu J; Qian J; Luo C Oncol Rep; 2020 Jan; 43(1):188-200. PubMed ID: 31746408 [TBL] [Abstract][Full Text] [Related]
9. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma. Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434 [TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome. Bai Y; Zhang QG; Wang XH Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217 [TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p. Jiang G; Dong H; Dong Y; Yang X Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416 [TBL] [Abstract][Full Text] [Related]
13. Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme. England B; Huang T; Karsy M Tumour Biol; 2013 Aug; 34(4):2063-74. PubMed ID: 23737287 [TBL] [Abstract][Full Text] [Related]
14. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17. Guo XB; Zhang XC; Chen P; Ma LM; Shen ZQ Oncol Rep; 2019 Nov; 42(5):1957-1971. PubMed ID: 31432186 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of NUSAP1 in progression and expansion of glioblastoma multiforme. Qian Z; Li Y; Ma J; Xue Y; Xi Y; Hong L; Dai X; Zhang Y; Ji X; Chen Y; Sheng M; Sheng Y; Yang L; Liu J; Dai X; Shi J; Xie T; Dong J J Neurooncol; 2018 Nov; 140(2):199-208. PubMed ID: 29995176 [TBL] [Abstract][Full Text] [Related]
16. Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma. Martins EP; Gonçalves CS; Pojo M; Carvalho R; Ribeiro AS; Miranda-Gonçalves V; Taipa R; Pardal F; Pinto AA; Custódia C; Faria CC; Baltazar F; Sousa N; Paredes J; Costa BM Mol Oncol; 2022 Jul; 16(14):2611-2631. PubMed ID: 34919784 [TBL] [Abstract][Full Text] [Related]
17. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival. Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatic analysis of the potential molecular mechanism of PAK7 expression in glioblastoma. Wang X; Liu S; Shao Z; Zhang P Mol Med Rep; 2020 Aug; 22(2):1362-1372. PubMed ID: 32626960 [TBL] [Abstract][Full Text] [Related]
19. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis. Chen X; Pan Y; Yan M; Bao G; Sun X Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990 [TBL] [Abstract][Full Text] [Related]
20. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome. Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]